Milestone Pharmaceuticals Inc.

NASDAQ:MIST

Biotechnology

Healthcare
$0.46 -0.01%

-$0.00 today

Market cap
$57.32M
Beta
0.96
P/E (TTM)
-2.5
EPS (TTM)
-$0.52
52W Low $1.00High $3.06

Volume 2.23M

Average 1.99M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$49.04M

FY 2025 · Annual

Investing Cash Flow

$11.25M

FY 2025 · Annual

+35.8% YoY

Financing Cash Flow

$85.53M

FY 2025 · Annual

+166.3% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(42.85M)(58.39M)(59.69M)(41.52M)(63.06M)
Depreciation & Amortization362K89K92K105K114K
Deferred Income Tax00000
Stock-Based Compensation7.28M9.05M9.53M5.78M7.46M
Change in Working Capital1.62M(3.26M)1.24M3.66M2.68M
Accounts Receivables96K(730K)(2.64M)1.46M(1.12M)
Inventory0000(648K)
Accounts Payables00004.43M
Other Working Capital1.52M(2.53M)3.88M2.2M17K
Other Non-Cash Items368K44K2.39M3.13M3.76M
Operating Cash Flow(33.22M)(52.47M)(46.42M)(28.85M)(49.04M)
Capital Expenditures0(272K)(112K)(33K)(302K)
Acquisitions (Net)00000
Purchases of Investments(15M)(85.85M)(137.13M)(113.55M)(82.92M)
Sales of Investments85M29M142M121.87M94.47M
Other Investing Activities00000
Investing Cash Flow70M(57.12M)4.76M8.28M11.25M
Debt Repayment0050M00
Common Stock Issued02.63M027.26M85.53M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities5.06M458K(2.21M)4.86M0
Financing Cash Flow5.06M3.09M47.79M32.12M85.53M
Effect of Forex Changes00000
Net Change in Cash41.83M(106.51M)6.12M11.55M47.73M
Free Cash Flow(33.22M)(52.74M)(46.54M)(28.88M)(49.34M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$63.1M
+ D&A$114.0K
+ Stock-Based Comp$7.5M
+ Deferred Tax$0
+ Working Capital$2.7M
+ Other Non-Cash$3.8M
= Operating Cash Flow-$49.0M
- Capex-$302.0K
= Free Cash Flow-$49.3M

Analysis

FY2025 free cash flow is -$49.3M. FCF conversion is 78.3% of net income. Operating cash flow was -$49.0M, with capex of -$302.0K. The largest bridge item is Stock-Based Comp at $7.5M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 13, 2026
8-KCurrent reportNov 13, 2026
8-KCurrent reportOct 28, 2026
8-KCurrent reportSep 3, 2026
8-KCurrent reportAug 12, 2026

Does MIST generate free cash flow?

Milestone Pharmaceuticals Inc. (MIST) generated -$49.34M of free cash flow in fiscal 2025.

How much operating cash flow does MIST produce?

Operating cash flow was -$49.04M, before capital expenditures of $302,000.00.